[REGN] YoY Quarter Result on 31-Dec-2023 [#Q4]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
05-Feb-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- 15.06%
YoY- -3.13%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 3,434,300 3,414,400 4,951,700 2,422,900 2,169,500 1,927,800 1,582,447 13.77%
PBT 1,147,600 1,324,700 2,503,400 1,224,600 889,800 676,200 554,767 12.87%
Tax -12,000 127,600 274,400 75,400 97,800 -144,200 381,248 -
NP 1,159,600 1,197,100 2,229,000 1,149,200 792,000 820,400 173,519 37.22%
Tax Rate 1.05% -9.63% -10.96% -6.16% -10.99% 21.33% -68.72% -
Total Cost 2,274,700 2,217,300 2,722,700 1,273,700 1,377,500 1,107,400 1,408,928 8.30%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin 33.77 35.06 45.01 47.43 36.51 42.56 10.97 20.60%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS 10.88 11.19 20.99 10.90 7.25 7.58 1.62 37.33%
EPS Diluted 10.19 10.50 19.69 10.24 6.93 7.15 1.49 37.75%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.